Miglustat Capsule
Product Images NDC 70710-2039

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Miglustat (NDC 70710-2039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3b0d8e2b B3c4 4a26 A126 420f56734843 01)

Chemical structure diagram of the active ingredient Miglustat, depicting its molecular arrangement with labeled carbon positions and hydroxyl groups as seen in the structure formula.*

FDA Label Image

Blister-card (3b0d8e2b B3c4 4a26 A126 420f56734843 02)

Miglustat 100 mg capsules label panels show the product name as migLUstat Capsule with a strength of 100 mg. Distributed by Zydus Pharmaceuticals (USA) Inc., the labels include space for lot and expiration dates, a barcode with NDC 70710-2039, and Rx only designation on one panel. The labels are arranged in a repeated grid layout for cutting or dispensing.*

FDA Label Image

Carton (3b0d8e2b B3c4 4a26 A126 420f56734843 03)

Miglustat 100 mg per capsule oral capsules packaging label showing a 90 capsule count (six blister cards of 15 capsules each), distributed by Zydus Pharmaceuticals USA Inc. The label states the package is not child resistant and is intended for oral use by prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.